Purinergic signaling to terminate TLR responses in macrophages

Frontiers in Immunology

Volumn 7, Issue MAR, 2016, Pages

  Hamidzadeh, Kajal ^a   Mosser, David M ^a  

^a Bldg 142   (United States)

Author keywords

Adenosine; ATP; Autoimmunity; CD39; CD73; Glycolysis; IFN

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; CD39 ANTIGEN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 4; PATHOGEN ASSOCIATED MOLECULAR PATTERN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84964662673     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00074     Document Type: Review

References (54)

1. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol (2002) 20(1):197-216. doi: 10.1146/annurev.immunol.20.083001.084359
2. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol (2005) 6(12):1191-7. doi:10.1038/ni1276
3. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol (2002) 2(10):787-95. doi:10.1038/nri915
4. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 8(12):958-69. doi:10.1038/nri2448
5. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature (2013) 496(7446):445-55. doi:10.1038/nature12034
6. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 11(11):750-61. doi:10.1038/nri3088
7. Nilsson R, Bajic VB, Suzuki H, di Bernardo D, Björkegren J, Katayama S, et al. Transcriptional network dynamics in macrophage activation. Genomics (2006) 88(2):133-42. doi:10.1016/j.ygeno.2006.03.022
8. Beyer M, Mallmann MR, Xue J, Staratschek-Jox A, Vorholt D, Krebs W, et al. High-resolution transcriptome of human macrophages. PLoS One (2012) 7(9):e45466. doi:10.1371/journal.pone.0045466
9. Price CTD, Abu Kwaik Y. The transcriptome of Legionella pneumophila-infected human monocyte-derived macrophages. PLoS One (2014) 9(12):e114914. doi:10.1371/journal.pone.0114914
10. Bent ZW, Poorey K, Brazel DM, LaBauve AE, Sinha A, Curtis DJ, et al. Transcriptomic analysis of Yersinia enterocolitica biovar 1B infecting murine macrophages reveals new mechanisms of extracellular and intracellular survival. Infect Immun (2015) 83(7):2672-85. doi:10.1128/IAI.02922-14
11. Mavromatis CH, Bokil NJ, Totsika M, Kakkanat A, Schaale K, Cannistraci CV, et al. The co-transcriptome of uropathogenic Escherichia coli-infected mouse macrophages reveals new insights into host-pathogen interactions. Cell Microbiol (2015) 17(5):730-46. doi:10.1111/cmi.12397
12. Fleming BD, Chandrasekaran P, Dillon LA, Dalby E, Suresh R, Sarkar A, et al. The generation of macrophages with anti-inflammatory activity in the absence of STAT6 signaling. J Leukoc Biol (2015) 98(3):395-407. doi:10.1189/jlb.2A1114-560R
13. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity (2014) 40(2):274-88. doi:10.1016/j.immuni.2014.01.006
14. Galvan-Pena S, O'Neill LAJ. Metabolic reprograming in macrophage polarization. Front Immunol (2014) 5:420. doi:10.3389/fimmu.2014.00420
15. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature (2013) 496(7444):238-42. doi:10.1038/nature11986
16. Cohen HB, Briggs KT, Marino JP, Ravid K, Robson SC, Mosser DM. TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses. Blood (2013) 122(11):1935-45. doi:10.1182/blood-2013-04-496216
17. Gorman MW, Feigl EO, Buffington CW. Human plasma ATP concentration. Clin Chem (2007) 53(2):318-25. doi:10.1373/clinchem.2006.076364
18. Bours MJL, Swennen ELR, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther (2006) 112(2):358-404. doi:10.1016/j.pharmthera.2005.04.013
19. Lazarowski ER, Boucher RC, Harden TK. Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem (2000) 275(40):31061-8. doi:10.1074/jbc. M003255200
20. Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, et al. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 271(51):33116-22. doi:10.1074/jbc.271.51.33116
21. Zimmermann H, Braun N. Ecto-nucleotidases-molecular structures, catalytic properties, and functional roles in the nervous system. Prog Brain Res (1999) 120:371-85. doi:10.1016/S0079-6123(08)63570-0
22. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, et al. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest (2002) 110(7):993-1002. doi:10.1172/JCI15337
23. Zanin RF, Braganhol E, Bergamin LS, Campesato LF, Filho AZ, Moreira JC, et al. Differential macrophage activation alters the expression profile of NTPDase and ecto-5'-nucleotidase. PLoS One (2012) 7(2):e31205. doi:10.1371/journal.pone.0031205
24. Liao H, Hyman MC, Baek AE, Fukase K, Pinsky DJ. cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. J Biol Chem (2010) 285(19):14791-805. doi:10.1074/jbc. M110.116905
25. Baek AE, Kanthi Y, Sutton NR, Liao H, Pinsky DJ. Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3). FASEB J (2013) 27(11):4419-28. doi:10.1096/fj.13-234625
26. Eichin D, Laurila JP, Jalkanen S, Salmi M. CD73 activity is dispensable for the polarization of M2 macrophages. PLoS One (2015) 10(8):e0134721. doi:10.1371/journal.pone.0134721
27. Csóka B, Németh ZH, Töro G, Koscsó B, Kókai E, Robson SC, et al. CD39 improves survival in microbial sepsis by attenuating systemic inflammation. FASEB J (2015) 29(1):25-36. doi:10.1096/fj.14-253567
28. Haskó G, Csóka B, Koscsó B, Chandra R, Pacher P, Thompson LF, et al. Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis. J Immunol (2011) 187(8):4256-67. doi:10.4049/jimmunol.1003379
29. Haskó G, Cronstein B. Regulation of inflammation by adenosine. Front Immunol (2013) 4:85. doi:10.3389/fimmu.2013.00085
30. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol (2000) 362(4-5):364-74. doi:10.1007/s002100000313
31. Olah ME. Identification of A2a adenosine receptor domains involved in selective coupling to Gs. Analysis of chimeric A1/A2a adenosine receptors. J Biol Chem (1997) 272(1):337-44.
32. Pierce KD, Furlong TJ, Selbie LA, Shine J. Molecular cloning and expression of an adenosine A2b receptor from human brain. Biochem Biophys Res Commun (1992) 187(1):86-93. doi:10.1016/S0006-291X(05)81462-7
33. Németh ZH, Lutz CS, Csóka B, Deitch EA, Leibovich SJ, Gause WC, et al. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J Immunol (2005) 175(12):8260-70. doi:10.4049/jimmunol.175.12.8260
34. Kreckler LM, Wan TC, Ge Z-D, Auchampach JA. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther (2006) 317(1):172-80. doi:10.1124/jpet.105.096016
35. Kreckler LM, Gizewski E, Wan TC, Auchampach JA. Adenosine suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production by murine macrophages through a protein kinase A-and exchange protein activated by cAMP-independent signaling pathway. J Pharmacol Exp Ther (2009) 331(3):1051-61. doi:10.1124/jpet.109.157651
36. Wall EA, Zavzavadjian JR, Chang MS, Randhawa B, Zhu X, Hsueh RC, et al. Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105. Sci Signal (2009) 2(75):ra28. doi:10.1126/scisignal.2000202
37. Sun Y, Duan Y, Eisenstein AS, Hu W, Quintana A, Lam WK, et al. A novel mechanism of control of NFκB activation and inflammation involving A2B adenosine receptors. J Cell Sci (2012) 125(19):4507-17. doi:10.1242/jcs.105023
38. Fredholm BB, Cunha RA, Svenningsson P. Pharmacology of adenosine A2A receptors and therapeutic applications. Curr Top Med Chem (2003) 3(4):413-26. doi:10.2174/1568026033392200
39. Aherne CM, Kewley EM, Eltzschig HK. The resurgence of A2B adenosine receptor signaling. Biochim Biophys Acta (2011) 1808(5):1329-39. doi:10.1016/j.bbamem.2010.05.016
40. Yasuda N, Inoue T, Horizoe T, Nagata K, Minami H, Kawata T, et al. Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes. Eur J Pharmacol (2003) 459(2-3):159-66. doi:10.1016/S0014-2999(02)02832-7
41. Gonzalez-Benitez E, Guinzberg R, Diaz-Cruz A, Pina E. Regulation of glycogen metabolism in hepatocytes through adenosine receptors. Role of Ca2+ and cAMP. Eur J Pharmacol (2002) 437(3):105-11. doi:10.1016/S0014-2999(02)01299-2
42. Johnston-Cox H, Koupenova M, Yang D, Corkey B, Gokce N, Farb MG, et al. The A2B adenosine receptor modulates glucose homeostasis and obesity. PLoS One (2012) 7(7):e40584. doi:10.1371/journal.pone.0040584
43. Chhabra P, Linden J, Lobo P, Okusa MD, Brayman KL. The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation. Curr Diabetes Rev (2012) 8(6):419-33. doi:10.2174/157339912803529878
44. Reiss AB, Rahman MM, Chan ESL, Montesinos MC, Awadallah NW, Cronstein BN. Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages. J Leukoc Biol (2004) 76(3):727-34. doi:10.1189/jlb.0204107
45. Gessi S, Fogli E, Sacchetto V, Merighi S, Varani K, Preti D, et al. Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler Thromb Vasc Biol (2010) 30(1):90-7. doi:10.1161/ATVBAHA.109.194902
46. Wang H, Zhang W, Zhu C, Bucher C, Blazar BR, Zhang C, et al. Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis. Arterioscler Thromb Vasc Biol (2009) 29(7):1046-52. doi:10.1161/ATVBAHA.109.188839
47. Montesinos MC, Desai-Merchant A, Cronstein BN. Promotion of wound healing by an agonist of adenosine A receptor is dependent on tissue plasminogen activator. Inflammation (2015) 38(6):2036-41. doi:10.1007/s10753-015-0184-3
48. Porta C, Riboldi E, Ippolito A, Sica A. Molecular and epigenetic basis of macrophage polarized activation. Semin Immunol (2015) 27(4):237-48. doi:10.1016/j.smim.2015.10.003
49. Schultze JL. Reprogramming of macrophages-new opportunities for therapeutic targeting. Curr Opin Pharmacol (2015) 26:10-5. doi:10.1016/j.coph.2015.09.007
50. Cohen HB, Ward A, Hamidzadeh K, Ravid K, Mosser DM. IFN-gamma prevents adenosine receptor (A2bR) upregulation to sustain the macrophage activation response. J Immunol (2015) 195(8):3828-37. doi:10.4049/jimmunol.1501139
51. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med (1993) 178(2):567-77. doi:10.1084/jem.178.2.567
52. Hu X, Chakravarty SD, Ivashkiv LB. Regulation of interferon and toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev (2008) 226:41-56. doi:10.1111/j.1600-065X.2008.00707.x
53. Gordon RA, Grigoriev G, Lee A, Kalliolias GD, Ivashkiv LB. The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor alpha and counter-regulated by the synovial fluid microenvironment. Arthritis Rheum (2012) 64(10):3119-28. doi:10.1002/art.34544
54. Cohen HB, Mosser DM. Extrinsic and intrinsic control of macrophage inflammatory responses. J Leuk Biol (2013) 94:913-9. doi:10.1189/jlb0413236